Emergence of Pseudomonas aeruginosa strains producing metallo-β-lactamases of the IMP-15 and VIM-2 types in Mexico

被引：26
|
作者：
Quinones-Falconi, F. [2 ]
Galicia-Velasco, M. [2 ]
Marchiaro, P. [1 ]
Mussi, M. A. [1 ]
Ballerini, V. [4 ]
Vila, A. J. [3 ]
Viale, A. M. [1 ]
Bermejo-Morales, K. [2 ]
Limansky, A. S. [1 ]
机构：
[1] Univ Nacl Rosario, Dept Microbiol, Inst Biol Mol & Celular Rosario, CONICET,Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Santa Fe, Argentina
[2] Inst Nacl Enfermedades Resp, Serv Microbiol Clin, Mexico City, DF, Mexico
[3] Univ Nacl Rosario, Dept Quim Biol, Inst Biol Mol & Celular Rosario, CONICET,Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Santa Fe, Argentina
[4] Hosp Intendente Carrasco, Dept Bioquim Municipal, Secretaria Salud Publ, Rosario, Santa Fe, Argentina
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2010年 / 16卷 / 02期
关键词：
Carbapenem resistance; IMP-15; metallo-beta-lactamases; Pseudomonas aeruginosa; VIM-2; GRAM-NEGATIVE PATHOGENS; CLASS-1; INTEGRON; UNITED-STATES; RESISTANCE; BLA(VIM-2); BACTERIA; GENE;
D O I：
10.1111/j.1469-0691.2009.02780.x
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Eighty-six carbapenem non-susceptible Pseudomonas aeruginosa isolates collected in the National Institute of Respiratory Diseases of Mexico City were screened for the presence of metallo-beta-lactamase (MBL) activity using both E-test strips and a microbiological assay with EDTA-imipenem. Genomic comparisons and sequence analyses conducted with these isolates revealed the presence of bla(VIM-2) in two clonally related isolates, and bla(IMP-15) in a clonally unrelated isolate. Both genes were found to be carried by class 1 integrons, and bla(IMP-15) was additionally present on a broad host-range plasmid. This is the first report of co-existing P. aeruginosa strains producing different MBLs in a Mexican hospital, highlighting the necessity of appropriate surveillance to prevent dissemination of carbapenem resistance.
引用
收藏
页码：126 / 131
页数：6
相关论文
共 50 条
  • [21] Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital:: clinical and epidemiological implications
    Pena, C.
    Suarez, C.
    Tubau, F.
    Gutierrez, O.
    Dominguez, A.
    Oliver, A.
    Pujol, M.
    Gudiol, F.
    Ariza, J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (10) : 1026 - 1029
  • [22] Infrequent Finding of Metallo-β-Lactamase VIM-2 in Carbapenem-Resistant Pseudomonas aeruginosa Strains from Croatia
    Sardelic, Sanda
    Bedenic, Branka
    Colinon-Dupuich, Celine
    Orhanovic, Stjepan
    Bosnjak, Zrinka
    Plecko, Vanda
    Cournoyer, Benoit
    Rossolini, Gian Maria
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (05) : 2746 - 2749
  • [23] First detection of metallo-β-lactamase VIM-2 in Pseudomonas aeruginosa isolates from Colombia
    Villegas, MV
    Lolans, K
    Olivera, MD
    Suarez, CJ
    Correa, A
    Queenan, AM
    Quinn, JP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) : 226 - 229
  • [24] Probing the Interaction of Aspergillomarasmine A with Metallo-β-lactamases NDM-1, VIM-2, and IMP-7
    Bergstrom, Alexander
    Katko, Andrew
    Adkins, Zach
    Hill, Jessica
    Cheng, Zishuo
    Burnett, Mia
    Yang, Hao
    Aitha, Mahesh
    Mehaffey, M. Rachel
    Brodbelt, Jennifer S.
    Tehrani, Kamaleddin H. M. E.
    Martin, Nathaniel I.
    Bonomo, Robert A.
    Page, Richard C.
    Tierney, David L.
    Fast, Walter
    Wright, Gerard D.
    Crowder, Michael W.
    ACS INFECTIOUS DISEASES, 2018, 4 (02): : 135 - 145
  • [25] Metallo-β-lactamase VIM-2 in Pseudomonas aeruginosa isolates from a cystic fibrosis patient
    Cardoso, Olga
    Alves, Ana Florinda
    Leitao, Rui
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (04) : 375 - 379
  • [26] α-Aminophosphonate inhibitors of metallo-β-lactamases NDM-1 and VIM-2
    Palica, Katarzyna
    Deufel, Fritz
    Skagseth, Susann
    Metzler, Gabriela Paula Di Santo
    Thoma, Johannes
    Rasmussen, Anna Andersson
    Valkonen, Arto
    Sunnerhagen, Per
    Leiros, Hanna-Kirsti S.
    Andersson, Hanna
    Erdelyi, Mate
    RSC MEDICINAL CHEMISTRY, 2023, 14 (11): : 2277 - 2300
  • [27] Carbapenem-hydrolysing VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Greece
    Mavroidi, A
    Tsakris, A
    Tzelepi, E
    Pournaras, S
    Loukova, V
    Tzouvelekis, LS
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) : 1041 - 1043
  • [28] First detection in Europe of the metallo--lactamase IMP-15 in clinical strains of Pseudomonas putida and Pseudomonas aeruginosa
    Gilarranz, R.
    Juan, C.
    Castillo-Vera, J.
    Chamizo, F. J.
    Artiles, F.
    Alamo, I.
    Oliver, A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (09) : E424 - E427
  • [29] VIM-2 metallo-β-lactamases genes found in Pseudomonas aeruginosa and Acinetobacter spp. from Russia and associated with unusual integrons
    Toleman, M. A.
    Collin, I.
    Sidorenko, S.
    Cherkashyn, E.
    Ivanov, D.
    Tishkov, V.
    Walsh, T. R.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S106 - S106
  • [30] First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-β-lactamase (VIM-2) in the United States
    Lolans, K
    Queenan, AM
    Bush, K
    Sahud, A
    Quinn, JP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) : 3538 - 3540
12345